Press Releases April 23, 2026 05:30 PM

TEN Ltd. Announces an Up to Five-Year Charter Extension of Two DP2 Shuttle Tankers

TEN Ltd. Extends Charters on Two DP2 Shuttle Tankers, Strengthening Multi-Billion Dollar Revenue Backlog

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
TEN

Tsakos Energy Navigation Ltd. announced up to five-year extensions for two DP2 shuttle tankers' charters, continuing contracts originally started in 2013. These extensions are anticipated to generate over $200 million in gross revenues and contribute to a $4 billion minimum fleet revenue backlog, reflecting TEN's robust positioning in the shuttle tanker market and ongoing partnerships with major oil companies.

TEN Ltd. Announces an Up to Five-Year Charter Extension of Two DP2 Shuttle Tankers
TEN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Extension of two DP2 shuttle tanker charters for up to five years beginning mid-2028.
  • Expected gross revenues exceeding $200 million from these charters.
  • TEN's fleet comprises 83 diversified energy vessels, making it a leading operator in the shuttle tanker segment.
  • The extensions contribute to a $4.0 billion minimum revenue backlog, indicating strong future cash flow potential.

$4.0 billion in minimum fleet revenue-backlog

Tanker markets continue at record levels

ATHENS, Greece, April 23, 2026 (GLOBE NEWSWIRE) -- TEN Ltd. (“TEN” or the “Company”) (NYSE: TEN) today announced the employment extension for two DP2 shuttle tankers, in direct continuation of the existing charters which commenced at delivery back in 2013, for up to five years each. These new charters are scheduled to come into effect upon expiration of the existing 15-year contracts around mid-2028 and are expected to generate gross revenues in excess of $200 million over their duration.

“Since our entry into the shuttle tanker market in 2013 with these two vessels, TEN has become one of the largest operators in that segment with a proforma fleet of 16 modern vessels and growing,” stated Mr. George Saroglou, President of TEN. “TEN continues its tested policy of long partnership with major oil concerns that secure future cash flow growth, strong balance sheet and continuous dividends to reward its shareholders,” Mr. Saroglou concluded.

ABOUT TEN Ltd.
Founded in 1993 and celebrating 33 years as a public company, TEN is one of the first and most established public shipping companies in the world. TEN's diversified energy fleet currently consists of 83 vessels, including ten DP2 shuttle tankers, three VLCCs, five scrubber-fitted LR1 tankers and one LNG carrier under construction, consisting of a mix of crude tankers, product tankers and LNG carriers totaling approximately 11 million dwt.

ABOUT FORWARD-LOOKING STATEMENTS
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. TEN undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

For further information, please contact:

Company
Tsakos Energy Navigation Ltd.
George Saroglou
President & COO
+30210 94 07 710
gsaroglou@tenn.gr

Investor Relations / Media
Capital Link, Inc.
Nicolas Bornozis/ Markella Kara
+212 661 7566
ten@capitallink.com


Risks

  • Forward-looking statements indicate risks about actual future outcomes differing materially due to market or operational uncertainties.
  • Dependence on tanker market conditions, which although currently at record levels, can fluctuate.
  • Potential challenges in the global energy shipping sector, including regulatory changes and environmental compliance costs.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026